Galantamine Effects in Patients With Metabolic Syndrome
Condition(s):Abdominal Obesity Metabolic SyndromeLast Updated:February 15, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Abdominal Obesity Metabolic SyndromeLast Updated:February 15, 2017Completed
Condition(s):Alzheimer DiseaseLast Updated:May 1, 2014Terminated
Condition(s):Tobacco Use DisorderLast Updated:February 15, 2019Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:December 16, 2020Completed
Condition(s):Major Depression; Bipolar Depression; Schizoaffective DisorderLast Updated:December 3, 2012Completed
Condition(s):Alzheimer’s DiseaseLast Updated:September 19, 2013Terminated
Condition(s):Alzheimer DiseaseLast Updated:March 26, 2012Completed
Condition(s):SchizophreniaLast Updated:January 12, 2022Completed
Condition(s):Alzheimer DiseaseLast Updated:January 25, 2011Completed
Condition(s):Alzheimer Disease; Dementia; GalantamineLast Updated:May 23, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.